Zydus Plans a USD 20 Million Drug Plant in Sri Lanka, With Output Expected in 2028
India, Oct. 15 -- The innovation-led lifesciences company Zydus Lifesciences Limited is putting down roots in a new market. Together with a local partner, it has signed an agreement with the country's investment authority to build a factory, backed by a multi-phase budget and a target date for production. The announcement follows a quarter in which sales grew strongly while profit slipped, so investors will be asking how a project like this fits the bigger picture for a group still absorbing several recent acquisitions.
The Nifty 50 traded at 22,960, up 1.49%, while the Sensex gained 1.70% to 74,000 on Thursday. Against the backdrop of a broader market rally, Zydus Lifesciences Limited is in focus after its proposed joint venture with S...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.